The FDA on 30 August 2012 approved Linzess (linaclotide) from Forest Labs and Ironwood Pharma, to treat Chronic Idiopathic Constipation...
AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau...
Ironwood Pharmaceuticals announced that the Phase III clinical trial of its 72 µg dose of Linzess/Constella (linaclotide) in adults with...
Actavis and Ironwood Pharmaceuticals announced that top-line data demonstrate linaclotide (Linzess) met all primary and secondary endpoints, covering multiple abdominal...
Astellas Pharma and Ironwood Pharmaceuticals announced top-line results indicating that the Phase III clinical trial of Linzess (linaclotide) conducted in...